Literature DB >> 11034305

Nuclear factor Y activates the human xanthine oxidoreductase gene promoter.

E Martelin1, J J Palvimo, R Lapatto, K O Raivio.   

Abstract

To study the regulation of the human xanthine oxidoreductase (XOR) gene, we cloned 1.9 kb of the promoter region. In reporter gene assays, a construct encompassing nucleotides between 142 to +42 conferred maximal basal activity of the XOR promoter in 293T cells, in comparison with shorter (-92 to +42) or longer (up to -1937 to +42) constructs. The promoter activity was low in NIH-3T3 cells. The most active construct contained a putative CCAAT motif at -119 to -123. Electrophoretic mobility shift assays showed that this sequence binds the ubiquitous nuclear factor Y (NF-Y). Mutation of the CCAAT motif (CTGAT) abolished the NF-Y binding and considerably reduced the promoter activity. Our data suggest an important functional role for NF-Y in the transcriptional activation of the human XOR gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11034305     DOI: 10.1016/s0014-5793(00)01909-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

Review 1.  The animal nuclear factor Y: an enigmatic and important heterotrimeric transcription factor.

Authors:  Guilin Li; Hang Zhao; Lijun Wang; Ying Wang; Xingqi Guo; Baohua Xu
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

2.  Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y).

Authors:  Yuwaraj Kadariya; Kaname Nakatani; Junji Nishioka; Takahiko Fujikawa; Warren D Kruger; Tsutomu Nobori
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

3.  Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase.

Authors:  Mehdi A Fini; David Orchard-Webb; Beata Kosmider; Jeremy D Amon; Robert Kelland; Gayle Shibao; Richard M Wright
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

Review 4.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.